EGF decreases the abundance of microRNAs that restrain oncogenic transcription factors
- PMID: 20516477
- DOI: 10.1126/scisignal.2000876
EGF decreases the abundance of microRNAs that restrain oncogenic transcription factors
Abstract
Epidermal growth factor (EGF) stimulates cells by launching gene expression programs that are frequently deregulated in cancer. MicroRNAs, which attenuate gene expression by binding complementary regions in messenger RNAs, are broadly implicated in cancer. Using genome-wide approaches, we showed that EGF stimulation initiates a coordinated transcriptional program of microRNAs and transcription factors. The earliest event involved a decrease in the abundance of a subset of 23 microRNAs. This step permitted rapid induction of oncogenic transcription factors, such as c-FOS, encoded by immediate early genes. In line with roles as suppressors of EGF receptor (EGFR) signaling, we report that the abundance of this early subset of microRNAs is decreased in breast and in brain tumors driven by the EGFR or the closely related HER2. These findings identify specific microRNAs as attenuators of growth factor signaling and oncogenesis.
Comment in
-
MicroRNAs add an additional layer to the complexity of cell signaling.Sci Signal. 2011 Jul 26;4(184):jc5. doi: 10.1126/scisignal.2002182. Sci Signal. 2011. PMID: 21868350 Review.
Similar articles
-
MicroRNAs add an additional layer to the complexity of cell signaling.Sci Signal. 2011 Jul 26;4(184):jc5. doi: 10.1126/scisignal.2002182. Sci Signal. 2011. PMID: 21868350 Review.
-
TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer.Sci Signal. 2011 Jun 14;4(177):ra41. doi: 10.1126/scisignal.2001538. Sci Signal. 2011. PMID: 21673316
-
EGF signalling in prostate cancer cell lines is inhibited by a high expression level of the endocytosis protein REPS2.Int J Cancer. 2005 Feb 10;113(4):561-7. doi: 10.1002/ijc.20612. Int J Cancer. 2005. PMID: 15455380
-
Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.Oncogene. 2006 Dec 7;25(58):7565-76. doi: 10.1038/sj.onc.1209740. Epub 2006 Jun 19. Oncogene. 2006. PMID: 16785991
-
Modulation of EGF receptor protooncogene expression by growth factors and hormones in human breast carcinoma cells.Crit Rev Oncog. 1991;2(2):173-85. Crit Rev Oncog. 1991. PMID: 1677274 Review.
Cited by
-
Inhibition of mutant EGFR in lung cancer cells triggers SOX2-FOXO6-dependent survival pathways.Elife. 2015 Feb 16;4:e06132. doi: 10.7554/eLife.06132. Elife. 2015. PMID: 25686219 Free PMC article.
-
A Proteomics Approach to Profiling the Temporal Translational Response to Stress and Growth.iScience. 2018 Nov 30;9:367-381. doi: 10.1016/j.isci.2018.11.004. Epub 2018 Nov 5. iScience. 2018. PMID: 30466063 Free PMC article.
-
Suppression of microRNA-9 by mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity.Cancer Res. 2014 Mar 1;74(5):1429-39. doi: 10.1158/0008-5472.CAN-13-2117. Epub 2014 Jan 16. Cancer Res. 2014. PMID: 24436148 Free PMC article.
-
Combined Influence of EGF+61G>A and TGFB+869T>C Functional Polymorphisms in Renal Cell Carcinoma Progression and Overall Survival: The Link to Plasma Circulating MiR-7 and MiR-221/222 Expression.PLoS One. 2015 Apr 24;10(4):e0103258. doi: 10.1371/journal.pone.0103258. eCollection 2014. PLoS One. 2015. PMID: 25909813 Free PMC article.
-
ERK-ERF-EGR1, a novel switch underlying acquisition of a motile phenotype.Cell Adh Migr. 2013 Jan-Feb;7(1):33-7. doi: 10.4161/cam.22263. Epub 2012 Oct 17. Cell Adh Migr. 2013. PMID: 23076209 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous